Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells
U Testa, G Castelli, E Pelosi - Cancers, 2018 - mdpi.com
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …
HIF-1-independent mechanisms regulating metabolic adaptation in hypoxic cancer cells
In solid tumours, cancer cells exist within hypoxic microenvironments, and their metabolic
adaptation to this hypoxia is driven by HIF-1 transcription factor, which is overexpressed in a …
adaptation to this hypoxia is driven by HIF-1 transcription factor, which is overexpressed in a …
Lysine demethylase KDM6A in differentiation, development, and cancer
ABSTRACT Lysine demethylase 6A (KDM6A), also known as UTX, belongs to the KDM6
family of histone H3 lysine 27 (H3K27) demethylases, which also includes UTY and KDM6B …
family of histone H3 lysine 27 (H3K27) demethylases, which also includes UTY and KDM6B …
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
Recent studies on mutations in cancer genomes have distinguished driver mutations from
passenger mutations, which occur as byproducts of cancer development. The cancer …
passenger mutations, which occur as byproducts of cancer development. The cancer …
[HTML][HTML] Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
Summary KRAS G12C inhibitors (adagrasib and sotorasib) have shown clinical promise in
targeting KRAS G12C-mutated lung cancers; however, most patients eventually develop …
targeting KRAS G12C-mutated lung cancers; however, most patients eventually develop …
UTX mutations in human cancer
L Wang, A Shilatifard - Cancer cell, 2019 - cell.com
Ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX, encoded by
KDM6A) is a histone demethylase that targets di-and tri-methylated histone H3 lysine 27 …
KDM6A) is a histone demethylase that targets di-and tri-methylated histone H3 lysine 27 …
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma
LL Zhou, T Zhang, Y Xue, C Yue, Y Pan… - Nature …, 2023 - nature.com
Chemo-activation of mitochondrial ClpP exhibits promising anticancer properties. However,
we are currently unaware of any studies using selective and potent ClpP activators in lung …
we are currently unaware of any studies using selective and potent ClpP activators in lung …
JMJD family proteins in cancer and inflammation
W Manni, X Jianxin, H Weiqi, C Siyuan… - Signal transduction and …, 2022 - nature.com
The occurrence of cancer entails a series of genetic mutations that favor uncontrollable
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …
Histone modification in NSCLC: molecular mechanisms and therapeutic targets
K Bajbouj, A Al-Ali, RK Ramakrishnan… - International journal of …, 2021 - mdpi.com
Lung cancer is the leading cause of cancer mortality in both genders, with non-small cell
lung cancer (NSCLC) accounting for about 85% of all lung cancers. At the time of diagnosis …
lung cancer (NSCLC) accounting for about 85% of all lung cancers. At the time of diagnosis …
Histone lysine demethylases and their functions in cancer
J Sterling, SV Menezes, RH Abbassi… - International Journal of …, 2021 - Wiley Online Library
Histone lysine demethylases (KDMs) are enzymes that remove the methylation marks on
lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene …
lysines in nucleosomes' histone tails. These changes in methylation marks regulate gene …